This study is for people aged 1 to 30 who have a type of cancer called **non-rhabdomyosarcoma soft tissue sarcoma (NRSTS)**. It will test a combination of medicines and treatments to see which work best. The study will use drugs like **pazopanib**, **selinexor**, **ifosfamide**, and **doxorubicin**. These drugs help stop cancer cells from growing. Some patients might also have surgery or radiation therapy.
**Key Points:**
- **Study Length:** This study involves various treatments and might require hospital visits and follow-ups.
- **Eligibility:** You must meet certain health requirements to join, like good heart and lung function.
- **Risks & Benefits:** There could be side effects from drugs. The study might help find better ways to treat NRSTS.
Before joining, you should discuss all risks, benefits, and requirements with your doctor to see if it's the right fit for you.
How understandable was the trial content above?
Hard to understand
Easy to understand